Israel Englander Gamida Cell Ltd. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.25 - $1.02 $610,151 - $2.49 Million	2,440,604 Added 1902.83%	2,568,866 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$0.73 - $2.37 $93,631 - $303,980	128,262 New	128,262 $247,000
Q4 2022 Feb 14, 2023	BUY	$1.15 - $2.1 $19,092 - $34,864	16,602 New	16,602 $21,000
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.46 $321,717 - $652,208	-146,235 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.85 - $6.44 $226,376 - $378,665	58,799 Added 67.25%	146,235 $573,000

Q2 2021 Aug 16, 2021	SELL	$5.85 - $8.33 $736,766 - $1.05 Million	-125,943 Reduced 59.02%	87,436 $560,000
Q1 2021 May 17, 2021	SELL	$7.8 - $12.43 $208,572 - $332,378	-26,740 Reduced 11.14%	213,379 $1.73 Million
Q4 2020 Feb 16, 2021	BUY	$4.07 - $11.0 $170,667 - $461,263	41,933 Added 21.16%	240,119 $2.02 Million
Q3 2020 Nov 16, 2020	SELL	$3.93 - $4.59 $291,892 - $340,913	-74,273 Reduced 27.26%	198,186 $822,000
Q2 2020 Aug 14, 2020	BUY	$2.79 - $6.5 $679,998 - $1.58 Million	243,727 Added 848.28%	272,459 $1.25 Million
Q1 2020 May 14, 2020	SELL	$2.9 - $4.76 $17,878 - $29,345	-6,165 Reduced 17.67%	28,732 $87,000
Q4 2019 Feb 14, 2020	SELL	$4.01 - $5.25 $137,061 - $179,445	-34,180 Reduced 49.48%	34,897 $150,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $5.09 $137,799 - $233,798	-45,933 Reduced 39.94%	69,077 $299,000
Q2 2019 Aug 15, 2019	BUY	$4.98 - $11.32 $243,771 - $554,114	48,950 Added 74.1%	115,010 $584,000
Q2 2019 Aug 14, 2019	BUY	$4.98 - $11.32 $234,378 - $532,764	47,064 Added 247.76%	66,060 $2.2 Million
Q1 2019 May 14, 2019	SELL	$9.8 - $14.38 $20,442 - $29,996	-2,086 Reduced 9.89%	18,996 $218,000
Q4 2018 Feb 14, 2019	BUY	$8.44 - $15.41 $177,932 - $324,873	21,082 New	21,082 $210,000

Others Institutions Holding GMDA

# of Institutions

Shares Held

11.4M

Call Options Held

235K

Put Options Held

70.5K

View Full List

About Gamida Cell Ltd.

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

More about GMDA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account